BSE Live
Dec 12, 09:46Prev. Close
331.15
Open Price
337.40
Bid Price (Qty.)
335.70 (54)
Offer Price (Qty.)
337.05 (30)
NSE Live
Dec 12, 09:46Prev. Close
332.30
Open Price
333.00
Bid Price (Qty.)
336.10 (3)
Offer Price (Qty.)
336.95 (1)
| Cash Flow of Panacea Biotec (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 112.77 | -86.67 | 187.69 | 211.86 | 98.67 | |
| Net CashFlow From Operating Activities | 62.17 | -6.84 | 66.81 | 156.99 | 159.89 | |
| Net Cash Used In Investing Activities | -117.18 | -115.27 | -383.85 | 172.42 | -111.57 | |
| Net Cash Used From Financing Activities | 27.56 | 159.91 | 221.07 | -234.97 | 381.31 | |
| Foreign Exchange Gains / Losses | -0.77 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -28.22 | 37.80 | -95.97 | 94.44 | 429.64 | |
| Cash And Cash Equivalents Begin of Year | 67.80 | 29.58 | 125.55 | 31.02 | 15.26 | |
| Cash And Cash Equivalents End Of Year | 39.58 | 67.38 | 29.58 | 125.47 | 444.90 |
27.11.2025
26.11.2025
Panacea Biotec Consolidated September 2025 Net Sales at Rs 141.13 crore, down 4.22% Y-o-Y
24.11.2025
Panacea Biotec Standalone September 2025 Net Sales at Rs 90.81 crore, up 18.49% Y-o-Y
11.06.2025
Panacea Biotec Standalone March 2025 Net Sales at Rs 67.90 crore, down 15.52% Y-o-Y
26.11.2025
Panacea Biotec Consolidated September 2025 Net Sales at Rs 141.13 crore, down 4.22% Y-o-Y
24.11.2025
Panacea Biotec Standalone September 2025 Net Sales at Rs 90.81 crore, up 18.49% Y-o-Y
11.06.2025
Panacea Biotec Standalone March 2025 Net Sales at Rs 67.90 crore, down 15.52% Y-o-Y
03.06.2025
Panacea Biotec Consolidated March 2025 Net Sales at Rs 132.53 crore, down 2.88% Y-o-Y